CMW Media

CMW Media
  • CMW Media
  • Quotes
  • Share:
  • Subscribe:
  • news.cision.com/
  • CMW Media
US/UK/Canada

Share

Quotes

With more than 300,000 deaths over the last eight years, substance abuse has been killing more people than any war.
Dr. Sanjay Gupta, President American Pain Association
Education and compassion are essential to achieving global acceptance of and access to cannabis.
Dr. Stuart Titus, CEO of Medical Marijuana, Inc.
"...may we reflect on how far we have come and continue to work toward the common goal of global cannabis access"
Dr. Stuart Titus, CEO of Medical Marijuana, Inc.
"The goal of these new advances in cannabis-based medicine – and the reintroduction of cannabis in healthcare – is to leave an indelible mark on the healthcare industry."
Dr. Stuart Titus, CEO of Medical Marijuana, Inc.
It is clear that cannabis has reached the tipping point in the minds of the U.S. population.
Dr. Stuart Titus, CEO of Medical Marijuana, Inc.
“It is clear that cannabis has reached the tipping point in the minds of the U.S. population.”
Dr. Stuart Titus, CEO - Medical Marijuana, Inc.
Pick a time period -
Tags ( Active)

MEDICAL MARIJUANA, INC. INVESTMENT AXIM® BIOTECHNOLOGIES, INC. PUBLISHES PRODUCT PIPELINE CHART FOR PHARMA CLINICAL TRIALS PROGRAM

Thu, Nov 03, 2016 14:15 CET

Cannabinoid Innovator’s Product Pipeline Highlights Timelines of Its Intellectual Property (IP) Protected Cannabinoid-Based Products from Pre-Clinical to NDA for Multiple IndicationsMedical Marijuana, Inc.  (OTC: MJNA) today announced that its investment AXIM® Biotechnologies, Inc. (AXIM® Biotech ) (OTC: AXIM), a world leader in cannabinoid research and development, has published a product pipeline chart  on its website that highlights the timelines from pre-clinical to a new drug application

There are no items matching the current filter
There are no more items matching the current filter
Back to top
©Cision
Privacy statement | Cookies | About | Content Policy | Contact    Cision
©Cision Privacy statement Cookies About Content Policy Contact

   Cision